Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127812161 | 12781216 | 1 | I | 20150810 | 20160926 | 20160926 | PER | US-GLENMARK PHARMACEUTICALS INC, USA.-2015GMK018975 | GLENMARK | QAMAR N, CHO S.. BRENTUXIMAB VEDOTIN DESENSITIZATION IN A FEMALE WITH RELAPSED,REFRACTORY,ANAPLASTIC LARGE-CELL LYMPHOMA (ALCL).. 2012 ANNUAL MEETING OF THE AMERICAN COLLEGE OF ALLERGY, ASTHMA AND IMMUNOLOGY.. 2012;109:A68 | 36.00 | YR | F | Y | 0.00000 | 20160926 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127812161 | 12781216 | 1 | PS | MONTELUKAST | MONTELUKAST SODIUM | 1 | Unknown | UNK | U | 90926 | |||||||||
| 127812161 | 12781216 | 2 | SS | MONTELUKAST | MONTELUKAST SODIUM | 1 | U | 90926 | |||||||||||
| 127812161 | 12781216 | 3 | SS | DIPHENHYDRAMINE. | DIPHENHYDRAMINE | 1 | Unknown | UNK | U | 0 | |||||||||
| 127812161 | 12781216 | 4 | SS | DIPHENHYDRAMINE. | DIPHENHYDRAMINE | 1 | U | 0 | |||||||||||
| 127812161 | 12781216 | 5 | SS | FAMOTIDINE. | FAMOTIDINE | 1 | Unknown | UNK | U | 0 | |||||||||
| 127812161 | 12781216 | 6 | SS | FAMOTIDINE. | FAMOTIDINE | 1 | U | 0 | |||||||||||
| 127812161 | 12781216 | 7 | SS | SOLU-MEDROL | METHYLPREDNISOLONE SODIUM SUCCINATE | 1 | Unknown | UNK | U | 0 | |||||||||
| 127812161 | 12781216 | 8 | SS | SOLU-MEDROL | METHYLPREDNISOLONE SODIUM SUCCINATE | 1 | U | 0 | |||||||||||
| 127812161 | 12781216 | 9 | SS | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | U | 0 | |||||||||||
| 127812161 | 12781216 | 10 | SS | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | U | 0 | |||||||||||
| 127812161 | 12781216 | 11 | C | BRENTUXIMAB VEDOTIN | BRENTUXIMAB VEDOTIN | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127812161 | 12781216 | 1 | Premedication |
| 127812161 | 12781216 | 2 | Immune tolerance induction |
| 127812161 | 12781216 | 3 | Anaphylactic reaction |
| 127812161 | 12781216 | 4 | Immune tolerance induction |
| 127812161 | 12781216 | 5 | Anaphylactic reaction |
| 127812161 | 12781216 | 6 | Immune tolerance induction |
| 127812161 | 12781216 | 7 | Anaphylactic reaction |
| 127812161 | 12781216 | 8 | Immune tolerance induction |
| 127812161 | 12781216 | 9 | Anaphylactic reaction |
| 127812161 | 12781216 | 10 | Immune tolerance induction |
| 127812161 | 12781216 | 11 | Anaplastic large cell lymphoma T- and null-cell types refractory |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127812161 | 12781216 | Off label use | |
| 127812161 | 12781216 | Therapeutic response unexpected |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |